• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Consumer Cyclical·AVRW
Share

Avenir Wellness Solutions, Inc. Stocks

$ 0Last Updated 20.10.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 16615

$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Avenir Wellness Solutions, Inc., operating through its subsidiary The Sera Labs, Inc., specializes in crafting advanced nutraceutical formulations and innovative delivery technologies. Their objective is to maximize product effectiveness and enhance overall well-being. The company offers a diverse range of products across the beauty, health and wellness, and pet care segments, sold under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brands. Distribution channels include major drugstores, supermarkets, convenience stores, and mass retailers. Additionally, Avenir Wellness Solutions supplies products under private labels to other retailers and multi-level marketing firms, and directly to consumers online, including through subscription services. Established in 2014, the company was formerly known as CURE Pharmaceutical Holding Corp. before adopting its current name in October 2022. Its corporate headquarters are located in Sherman Oaks, California.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.10.2026 13:03

The price of Brent crude oil exceeded $114 for the first time since May

23.10.2026 12:41

An Angry France: What Surprises Might Lie Ahead in the Upcoming Presidential Election?

23.10.2026 12:14

OpenAI had to lower its target valuation from $1.4 trillion to $1.25 trillion. Where did all the hype go?

23.10.2026 11:44

Kazakhstan's first "AI unicorn" has attracted investment from Nvidia

23.10.2026 10:40

Top Stories This Morning: Investors Sold Off AI Stocks; SK Hynix Canceled Solidigm's IPO

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026